Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 88,260,257
- Total 13F shares
- 88,660,945
- Share change
- +16,470,193
- Total reported value
- $1,915,962,261
- Put/Call ratio
- 110%
- Price per share
- $21.61
- Number of holders
- 176
- Value change
- +$405,830,138
- Number of buys
- 112
- Number of sells
- 75
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.7%
|
7,642,446
|
$110,968,316 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
5,882,636
|
$85,415,873 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
3,617,302
|
$52,523,225 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
3,600,648
|
$52,281,409 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
4.1%
|
3,600,000
|
$52,272,000 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
3.2%
|
2,821,000
|
$40,960,920 | — | 30 Sep 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
3.1%
|
2,715,235
|
$39,425,212 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
2.9%
|
2,596,245
|
$37,697,477 | — | 30 Sep 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.9%
|
2,555,555
|
$37,106,659 | — | 30 Sep 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.7%
|
2,390,077
|
$34,703,918 | — | 30 Sep 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.7%
|
2,347,673
|
$34,088,211 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.4%
|
2,094,201
|
$30,407,799 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,360,920
|
$19,763,029 | — | 30 Sep 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.5%
|
1,284,000
|
$18,643,680 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,267,748
|
$18,407,701 | — | 30 Sep 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
1.4%
|
1,236,186
|
$17,949,421 | — | 30 Sep 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.2%
|
1,066,548
|
$15,487,000 | — | 30 Sep 2023 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$14,883,000 | — | 30 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
1,000,000
|
$14,520,000 | — | 30 Sep 2023 | |
| Commodore Capital LP |
13F
|
Company |
1.1%
|
957,509
|
$13,903,031 | — | 30 Sep 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.1%
|
941,817
|
$13,675,183 | — | 30 Sep 2023 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
0.99%
|
875,000
|
$12,705,000 | — | 30 Sep 2023 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.92%
|
807,969
|
$11,731,710 | — | 30 Sep 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.88%
|
773,061
|
$11,224,846 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.83%
|
729,098
|
$10,586,503 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
635,525
|
$9,227,823 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.68%
|
603,962
|
$8,769,530 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.68%
|
600,000
|
$8,712,000 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.62%
|
550,029
|
$7,986,421 | — | 30 Sep 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.58%
|
514,852
|
$7,475,651 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.57%
|
506,467
|
$7,353,901 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.57%
|
499,521
|
$7,253,046 | — | 30 Sep 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
0.54%
|
472,600
|
$6,862,152 | — | 30 Sep 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.52%
|
458,373
|
$6,655,576 | — | 30 Sep 2023 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.52%
|
456,219
|
$6,624,000 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.5%
|
439,770
|
$6,385,460 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
435,493
|
$6,323,358 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.49%
|
431,565
|
$6,266,324 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.48%
|
422,008
|
$6,127,555 | — | 30 Sep 2023 | |
| Steve M. Sabus |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
220,000
|
$5,685,614 | — | 05 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.44%
|
390,538
|
$5,670,612 | — | 30 Sep 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.34%
|
297,035
|
$4,312,948 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.32%
|
284,124
|
$4,125,480 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.29%
|
259,858
|
$3,773,138 | — | 30 Sep 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.27%
|
240,031
|
$3,485,250 | — | 30 Sep 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.27%
|
240,010
|
$3,484,945 | — | 30 Sep 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.26%
|
232,466
|
$3,375,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
227,504
|
$3,303,359 | — | 30 Sep 2023 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
219,974
|
$3,194,022 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.25%
|
218,413
|
$3,171,356 | — | 30 Sep 2023 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q4 2023
As of 31 Dec 2023,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,660,945 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Kynam Capital Management, LP, STATE STREET CORP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, Avidity Partners Management LP, Eversept Partners, LP, Point72 Asset Management, L.P., and T. Rowe Price Investment Management, Inc..
This page lists
176
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
174
Q4 2023 holders
176
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.